Keros Therapeutics, Inc. (KROS)
17.91
-0.08
(-0.44%)
USD |
NASDAQ |
Jan 30, 16:00
17.88
-0.03
(-0.17%)
After-Hours: 20:00
Keros Therapeutics Market Cap : 545.65M for Jan. 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.409B |
| MannKind Corp. | 1.775B |
| Sarepta Therapeutics, Inc. | 2.131B |
| Insmed, Inc. | 33.46B |
| Ionis Pharmaceuticals, Inc. | 13.39B |
Market Cap Related Metrics
| PE Ratio | 11.61 |
| PS Ratio | 2.951 |
| Price to Book Value | 0.7755 |
| Price to Free Cash Flow | 8.360 |
| Price | 17.91 |
| Earnings Yield | 8.61% |
| Operating PE Ratio | 16.70 |
| Normalized PE Ratio | 11.61 |